Dermata Therapeutics (DRMA) News Today

→ Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad)

$0.28

-0.03 (-9.84%)

(As of 04/16/2024 ET)

Source

Source	Headline
	Dermata Therapeutics (NASDAQ:DRMA) Trading Down 3% americanbankingnews.com - April 10 at 2:20 AM
	Dermata Therapeutics, Inc. (DRMAW) ca.finance.yahoo.com - February 11 at 3:44 PM
	Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Now finance.yahoo.com - February 6 at 7:49 AM
	Dermata Therapeutics Inc DRMA morningstar.com - February 4 at 12:48 PM
	Dermata to Present at the Emerging Growth Conference on February 7, 2024 finance.yahoo.com - February 1 at 10:31 AM
	Dermata stock soars on patent issuance, partnership talks msn.com - January 7 at 2:38 AM
	Dow Turns Lower; ISM Services PMI Falls In December msn.com - January 5 at 5:22 PM
	Why Is Aesthetic Skin Conditions-Focused Dermata Therapeutics Stock Trading Higher Today? msn.com - January 5 at 12:22 PM
	Why Is Dermata Therapeutics (DRMA) Stock Up 62% Today? investorplace.com - January 5 at 9:12 AM
	Stocks to Watch: Dermata Therapeutics, Applied Therapeutics, Fusion Pharmaceuticals marketwatch.com - January 4 at 9:20 PM
	Dermata Therapeutics Shares Surge 120% on Patent Issued in Japan marketwatch.com - January 4 at 9:20 PM
	Why Dermata Therapeutics Stock Took Off After-Hours msn.com - January 4 at 9:20 PM
	Dermata Expands Global Intellectual Patent Portfolio with Issuance of Japanese Patent for DMT410 for the Treatment of Hyperhidrosis finance.yahoo.com - January 4 at 4:20 PM
	Dermata Therapeutics: Dermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne finanznachrichten.de - December 21 at 1:59 PM
	Dermata Therapeutics Stock (NASDAQ:DRMA) Dividends: History, Yield and Dates benzinga.com - December 20 at 8:31 PM
	Dermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne finance.yahoo.com - December 20 at 8:31 PM
	Dermata Therapeutics Inc. thestreet.com - December 13 at 2:42 AM
	Dermata Announces Exercise of Warrants for $2.26 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules finance.yahoo.com - November 16 at 1:39 PM
	Dermata to Begin Enrolling Patients in DMT310 Phase 3 Acne Clinical Program in December 2023 based on Agreement with FDA on the Phase 3 Protocols finance.yahoo.com - November 16 at 8:39 AM
	Dermata Therapeutics GAAP EPS of -$0.54 msn.com - November 10 at 10:22 AM
	Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results finance.yahoo.com - November 9 at 5:47 PM
	Dermata Therapeutics Completes Start-Up Activities to Support DMT310 Phase 3 STAR-1 Acne Trial finance.yahoo.com - October 26 at 1:47 PM
	Dermata to Present at the H.C. Wainwright 25th Annual Global Investment Conference finance.yahoo.com - August 31 at 5:27 PM
	Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results finance.yahoo.com - August 11 at 1:01 AM
	Dermata Therapeutics Announces Positive Feedback from FDA on the DMT310 Phase 3 Clinical Development Program in Moderate-to-Severe Acne finance.yahoo.com - June 27 at 9:05 AM
	Dermata Therapeutics to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET finance.yahoo.com - June 13 at 4:57 PM
	Journal of the American Academy of Dermatology Publishes Positive DMT310 Phase 2b Acne Results finance.yahoo.com - June 8 at 3:07 PM
	Dermata Therapeutics: Journal of the American Academy of Dermatology Publishes Positive DMT310 Phase 2b Acne Results finanznachrichten.de - June 8 at 10:07 AM
	Dermata Therapeutics Announces Closing of $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules finance.yahoo.com - May 26 at 4:37 PM
	Dermata Therapeutics Announces $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules finance.yahoo.com - May 24 at 10:06 AM
	Dermata Therapeutics announces $1.8M offering priced ATM msn.com - May 24 at 10:06 AM
	Dermata Therapeutics Announces $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules finance.yahoo.com - May 24 at 10:06 AM
	Dermata Therapeutics Shares Rally Premarket on DMT310 Update >DRMA marketwatch.com - May 12 at 10:32 AM
	Dermata Therapeutics GAAP EPS of -$2.27 seekingalpha.com - May 11 at 7:18 PM
	Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results finance.yahoo.com - May 11 at 7:18 PM
	Dermata Therapeutics awaits FDA go-ahead for lead candidate DMT310 to enter Phase 3 studies proactiveinvestors.com - May 9 at 5:12 PM
	Dermata (DRMA) Gains on Positive FDA Response for Acne Candidate finance.yahoo.com - April 21 at 6:39 PM
	Dermata Therapeutics: Dermata Announces Receipt of Type C Meeting Response from the FDA and Submission of DMT310 End of Phase 2 Meeting Package finanznachrichten.de - April 20 at 10:04 AM
	Dermata climbs ~28% after update on acne candidate msn.com - April 20 at 10:04 AM
	Dermata Announces Receipt of Type C Meeting Response from the FDA and Submission of DMT310 End of Phase 2 Meeting Package finance.yahoo.com - April 20 at 10:04 AM
	Dermata Therapeutics Inc (DRMA) has risen 6.40% Wednesday In Premarket Trading benzinga.com - March 31 at 8:01 AM
	Dermata Therapeutics Stock (NASDAQ:DRMA), Guidance and Forecast benzinga.com - March 26 at 3:24 PM
	Why Is Allarity Therapeutics (ALLR) Stock Down 23% Today? markets.businessinsider.com - March 24 at 9:52 AM
	marketbeat.com - March 23 at 2:56 PM
	Dermata Therapeutics Announces Closing of $5.0 Million Public Offering finance.yahoo.com - March 20 at 8:39 PM
	Dermata Therapeutics Announces Closing of $5.0 Million Public Offering finance.yahoo.com - March 20 at 8:39 PM
	Dermata Therapeutics Up 24% After Boosting Size of Offering marketwatch.com - March 16 at 2:39 PM
	Dermata Therapeutics Announces Pricing of $5.0 Million Public Offering finance.yahoo.com - March 16 at 2:39 PM
	DRMA Dermata Therapeutics, Inc. seekingalpha.com - February 28 at 4:38 AM
	Dermata Therapeutics Provides Corporate Update and Reports Full Year 2022 Financial Results finance.yahoo.com - February 21 at 6:59 PM

Get Dermata Therapeutics News Delivered to You Automatically

Can't believe it's happening again (Ad)

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

DRMA Media Mentions By Week

DRMA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DRMA
News Sentiment
▼
0.30

0.66
▲
Average
Medical
News Sentiment

DRMA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DRMA Articles
This Week
▼
2

0
▲
DRMA Articles
Average Week

Get Dermata Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:DRMA) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Dermata Therapeutics (DRMA) News Today

DRMA Media Mentions By Week

DRMA Media Sentiment

DRMA News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info